Carbonicacid, 1,1-dimethylethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylester (480438-74-2)

Identification
Name:	Carbonicacid, 1,1-dimethylethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylester
Synonyms:	3-(Tert-Butoxycarbonyloxy)phenylboronic acid pinacol ester;
CAS:	480438-74-2
Molecular Formula:	C₁₇H₂₅BO₅
Molecular Weight:	320.19
InChI:	InChI=1/C17H25BO5/c1-15(2,3)21-14(19)20-13-10-8-9-12(11-13)18-22-16(4,5)17(6,7)23-18/h8-11H,1-7H3
Molecular Structure:
Properties
Melting Point:	84-88 °C(lit.)
Flash Point:	203°C
Boiling Point:	412.1°C at 760 mmHg
Density:	1.08g/cm³
Refractive index:	1.494
Flash Point:	203°C
Safety Data

Other Product

Carbonicacid, 1,1-dimethylethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylester
1-(4-(5-(4,4,5,5-tetramethyl-1,3,2 -dioxaborolan-2-yl)pyridin-3-yl) piperazin-1-yl)ethanone
2-(3-methylpiperidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-4-carbonitrile
1-methyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)piperazine
1-(methylsulfonyl)-4-(5-(4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl)pyridin-3-yl)piperazine
tert-butyl 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]piperazine-1-carboxylate
1-Piperazinecarboxylicacid, 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]-,1,1-dimethylethyl ester
1-(2-Fluoro-5-methylphenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea
1-Methyl-4-[3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- yl)-2-pyridinyl]piperazine
1H-Indole, 1-[(1,1-diMethylethyl)diMethylsilyl]-5-fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-
1H-Indazole-3-carboxaldehyde,1-[(4-methoxyphenyl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
1-METHYL-N-[5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3-PYRIDINYL]-1H-IMIDAZOLE-4-SULFONAMIDE
2-Oxazolidinethione,3-[(2S,3R,4E)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methyl-1-oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-pentenyl]-4-(phenylmethyl)-, (4S)-
4-Penten-1-ol,3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, (2R,3R,4E)-
1-methoxy-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-5-yl]propan-2-ol
2-Oxazolidinone,3-[3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-5-(1H-1,2,3-triazol-1-ylmethyl)-, (5R)-
1H-Pyrrolo[2,3-b]pyridine, 3-(3-furanyl)-1-[(4-Methylphenyl)sulfonyl]-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-
1-Piperidinecarboxylic acid,4-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl]oxy]-,1,1-dimethylethyl ester
1H-Pyrrolo[2,3-b]pyridine,3-(2-methoxyphenyl)-1-[(4-methylphenyl)sulfonyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
1H-Pyrrolo[2,3-b]pyridine,3-(2-ethoxyphenyl)-1-[(4-methylphenyl)sulfonyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-